Medicamen Biotech Limited (BOM:531146)
India
· Delayed Price · Currency is INR 285.50
-6.00 (-2.06%)
At close: Mar 9, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.63 billion as of March 9, 2026. Its market cap has decreased by -39.20% in one year.
Market Cap
3.63B
Enterprise Value
3.58B
Revenue
1.72B
Ranking
n/a
PE Ratio
48.86
Stock Price
285.50
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.63B, an increase of 3,245.98%. That is a compound annual growth rate of 18.05%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Albert David | 3.88B |
| Amanta Healthcare | 3.46B |
| Medico Remedies | 3.46B |
| ZIM Laboratories | 3.26B |
| Trident Lifeline | 3.20B |
| Jenburkt Pharmaceuticals | 4.41B |
| Everest Organics | 2.97B |
| Gennex Laboratories | 2.67B |